Cargando…
Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two
OBJECTIVE: To analyse the short-term adverse effects (AEs) of propranolol in the treatment of infantile hemangiomas (IHs) and their relevant factors, as well as the relationship between child growth and propranolol. METHODS: A total of 506 patients with confirmed or suspected IHs were enrolled, and...
Autores principales: | Li, Xueqing, Yang, Kun, Li, Hongwen, Huo, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899275/ https://www.ncbi.nlm.nih.gov/pubmed/31886190 http://dx.doi.org/10.1155/2019/2728952 |
Ejemplares similares
-
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence
por: Xiao, Qiang, et al.
Publicado: (2013) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021) -
Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas
por: Lou, Huanmin, et al.
Publicado: (2018)